RPRX logo

Royalty Pharma plc (RPRX) EV/EBITDA

EV/EBITDA:

16.04+0.16(+1.01%)
December 11, 2025

Summary

  • As of today, RPRX EV/EBITDA is 16.04, with a rise of +0.16 (+1.01%) during the most recent trading session on December 11, 2025.
  • Over the past year, RPRX EV/EBITDA has increased by +6.77 (+73.03%).
  • RPRX EV/EBITDA is now -70.31% below its all-time high of 54.03.

Performance

RPRX EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

OtherRPRXvaluation metrics

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

RPRX EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise ValueEnterprise ValuePricePrice
1D1 Day+1.0%+1.0%+1.4%
1M1 Month-0.3%-0.3%-0.4%
3M3 Months+33.2%+5.8%+5.8%
6M6 Months+55.0%+17.9%+14.0%
YTDYTD+38.6%+36.6%+52.1%
1Y1 Year+73.0%+38.1%+54.0%
5Y5 Years+138.3%+22.4%-8.5%

RPRX EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs Highvs HighLowLowCurrent vs Lowvs Low
1M1-Month16.37-2.0%15.83+1.3%
3M3-Month16.58-3.3%11.63+37.9%
6M6-Month16.58-3.3%10.35+55.0%
1Y1-Year16.58-3.3%9.06+77.0%
3Y3-Year54.03-70.3%9.06+77.0%
5Y5-Year54.03-70.3%6.73+138.3%
All-TimeAll-Time54.03-70.3%5.69+181.9%

RPRX EV/EBITDA History

DateValue
2025
16.04(+38.6%)
2024
11.57(+20.0%)
2023
9.64(-82.2%)
DateValue
2022
54.03(+248.8%)
2021
15.49(+25.7%)
2020
12.32

FAQ

  • What is Royalty Pharma plc EV/EBITDA?
  • What is the all-time high EV/EBITDA for Royalty Pharma plc?
  • What is RPRX EV/EBITDA year-to-date change?
  • What is Royalty Pharma plc EV/EBITDA year-on-year change?

What is Royalty Pharma plc EV/EBITDA?

The current EV/EBITDA of RPRX is 16.04

What is the all-time high EV/EBITDA for Royalty Pharma plc?

Royalty Pharma plc all-time high EV/EBITDA is 54.03

What is RPRX EV/EBITDA year-to-date change?

Royalty Pharma plc EV/EBITDA has changed by +4.47 (+38.63%) since the beginning of the year

What is Royalty Pharma plc EV/EBITDA year-on-year change?

Over the past year, RPRX EV/EBITDA has changed by +6.77 (+73.03%)
On this page